Skip to main content
OpenTrials

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

94 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

Long-term Effect of Lanthanum Carbonate on Bone

NCT00557323

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Imperial care Dialysis Center Lynwood, California, United States
  • Barnett Research and Communications Medical Group Torrance, California, United States
  • Western new England Renal & Transplant Associates Springfield, Massachusetts, United States
  • Mercy Medical Center Canton, Ohio, United States
View all 19 locations
View Trial Details
Completed

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis

NCT01696279

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations
  • Centro Infantil Del Rinon S.R.L San Miguel de Tucumán, Tucumán Province, Argentina
  • Hospital Luis Calvo Mackenna Santiago, Chile
  • Hospital Dr. Sotero del Rio Santiago, Chile
  • Fakultni nemocnice Ostrava Ostrava, Czechia
View all 22 locations
View Trial Details
Completed

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

NCT00567723

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Clinical Research Center, Inc. Birmingham, Alabama, United States
  • Clinical Research Consultants Hoover, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Montgomery Kidney Specialists Montgomery, Alabama, United States
View all 199 locations
View Trial Details
Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT03984760

Conditions
Chronic Disease, Disease Attributes, ESRD, +16 more
Locations
  • Baotou Central Hospital Baotou, China
  • The General Hospital of the People's Liberation Army (PLAGH) Beijing, China
  • The Second Hospital of Jilin University Changchun, China
  • Daping Hospital Chongqing, China
View all 24 locations
View Trial Details
Completed

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

NCT01069692

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations
  • Novartis Investigative Site Jette, Belgium
  • Novartis Investigative Site Liège, Belgium
  • Novartis Investigative Site Roeselare, Belgium
  • Novartis Investigative Site Brescia, Italy
View Trial Details

Related conditions